ArticleAnnals of hematology2026

Neutropenia and infectious events during off-label treatment with venetoclax in children with malignant disease: a pharmacovigilance analysis of FDA adverse event reporting system reports.

Edoardo Muratore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.